Hemifacial Myohyperplasia Is Due to Somatic Muscular PIK3CA Gain-of-Function Mutations and Responds to Pharmacological Inhibition

To understand the physiopathology of muscle hypertrophy in this context, scientists created a mouse model carrying specifically a PIK3CA mutation in skeletal muscles.